Alisertib
- Generic Name
- Alisertib
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C27H20ClFN4O4
- CAS Number
- 1028486-01-2
- Unique Ingredient Identifier
- T66ES73M18
- Background
Alisertib is a novel aurora A kinase inhibitor under investigation for the treatment of various forms of cancer.
- Indication
For the treatment of various forms of cancer.
- Associated Conditions
- -
- Associated Therapies
- -
A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid Tumors
- First Posted Date
- 2007-07-13
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- Millennium Pharmaceuticals, Inc.
- Target Recruit Count
- 87
- Registration Number
- NCT00500903
- Locations
- 🇺🇸
Sarah Cannon Research Institute (SCRI), Nashville, Tennessee, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath